Trademark Attorney / Law Firm

KATHLEEN MCGILL GASKILL – Trademark Portfolio

KATHLEEN MCGILL GASKILL specializes in Class 35 (Advertising & Business) trademark filings before the United States Patent and Trademark Office (USPTO), with 1 of 2 total filings concentrated in this category. The practice also covers Class 5 (Pharmaceuticals) along with 2 other Nice Classification classes. Filing activity spans from 1983 to 1990. Currently, 0 trademarks are registered.

2 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

KATHLEEN MCGILL GASKILL's trademark practice covers 2 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademark applications has KATHLEEN MCGILL GASKILL filed?

KATHLEEN MCGILL GASKILL has filed 2 trademark applications with the United States Patent and Trademark Office (USPTO).

What trademark classes does KATHLEEN MCGILL GASKILL specialize in?

KATHLEEN MCGILL GASKILL has filed trademarks across 2 Nice Classification classes. The most common practice areas include Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

How long has KATHLEEN MCGILL GASKILL been filing trademarks?

KATHLEEN MCGILL GASKILL's trademark filing history with the USPTO spans from 1983 to 1990, covering 7 years of trademark practice. During this period, KATHLEEN MCGILL GASKILL has handled 2 trademark applications.

What is KATHLEEN MCGILL GASKILL's trademark registration success rate?

KATHLEEN MCGILL GASKILL has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.